Compare Humana Inc (HUM) vs Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF (PDBC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF — how do they compare? Humana Inc trades at $398.55 (market cap $47.81B), while Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF trades at $17.5. The key difference: Humana Inc pays a 0.89% dividend while Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF pays none, and Humana Inc is trading nearer its 52-week high, Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF nearer its low. Which is the better fit depends on your goals.
| HUM | PDBC | |
|---|---|---|
Market Cap | $47.81B | — |
Sector | Health | — |
52-Week High | $409.42 | $18.91 |
52-Week Low | $163.67 | $12.90 |
Enterprise Value | $56.85B | — |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $398.09, down 0.48% with a bullish technical signal from moving averages. The company shows strong revenue growth to $129.66B in 2025 but faces margin compression with net income margin declining to 0.82%. Recent earnings have consistently beaten expectations, and analyst sentiment is mixed with 34% buy ratings but a consensus price target of $354.33 below current levels.
The outlook suggests cautious optimism with Medicare Advantage expansion opportunities but significant margin pressure and regulatory risks. Key investment considerations include the company's ability to achieve its 3% Medicare Advantage margin target by 2028 while navigating increased healthcare utilization costs and competitive pressures in the insurance sector.
PDBC trades at $17.38, up 0.75% with strong institutional interest as Geneos Wealth Management increased its position by 150.6% in Q1 2026. The ETF shows bullish technical signals with moving averages supporting upward momentum, though RSI levels indicate potential overbought conditions. PDBC has delivered 37% returns since March 2024, outperforming the S&P 500 by nearly 10 percentage points, driven by commodity price strength and Middle East supply disruptions.
Outlook remains positive given commodity momentum and inflation hedging demand, but risks include recent commodity weakness and the fund's complex tax structure. The ETF's annual distribution is unpredictable, swinging with commodity prices, which may disappoint income-focused investors despite strong total returns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF
The fund is an actively managed exchange-traded fund ("ETF") that seeks to achieve its investment objective by investing in a combination of financial instruments that are economically linked to the world's most heavily traded commodities. Commodities are assets that have tangible properties, such as oil, agricultural produce or raw metals.
Read more on PDBC →
